VI-1121

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameVI-1121
Drug Alias NameVI-1121
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVivus LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVivus LLC
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A